CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Two-Drug punch knock out CMV faster in lung transplants?
Disease control Recruiting nowThis study tests whether adding letermovir to standard antiviral treatment helps clear cytomegalovirus (CMV) infection faster in people who have received a lung transplant. About 40 participants will receive either letermovir or a placebo alongside their usual medication for 21 d…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple infusion shield kidney transplants from a dangerous virus?
Disease control Recruiting nowThis study is testing whether a drug called Cytogam (CMVIG) can prevent cytomegalovirus (CMV) infection in kidney transplant patients who are switching to a new immunosuppressant. The researchers will measure antibody levels in 30 adult patients over 8 weeks to see how the drug w…
Matched conditions: CMV
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Extended antiviral therapy may shield transplant patients from dangerous virus
Prevention Recruiting nowThis study looks at whether giving letermovir for a longer time (up to 28 weeks) can prevent cytomegalovirus (CMV) infection in Chinese adults who have a high risk of reactivation after a stem cell transplant. Participants must be at least 18, have had a stem cell transplant, and…
Matched conditions: CMV
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Scientists hunt for genetic clues to severe viral infections
Knowledge-focused Recruiting nowThis study looks at people who have had unusually severe or long-lasting viral infections, like serious cases of herpes, HPV, or the flu. Researchers want to find out if these people have hidden immune system or genetic problems that make them more vulnerable. Up to 600 participa…
Matched conditions: CMV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC